South East Asia In Vitro Fertilization (IVF) Market Size, Share, Forecast, & Trends Analysis by Type (Natural, Intracytoplasmic, Minimal), Product (Imaging, Cryosystems, IVF Cabinets, Incubator, Media, Sperm Analyzer), Cycle, Application, End User - Forecast to 2031

The South East Asia In Vitro Fertilization (IVF) Market was valued at $128.6 million in 2023. This market is expected to reach $222.6 million by 2031 from an estimated $137.7 million in 2024, at a CAGR of 7.1% during the forecast period 2024-2031.

South East Asia In Vitro Fertilization (IVF) Market Size & Forecast

The growth of the South East Asia In Vitro Fertilization (IVF) market is primarily driven by increasing infertility rates, technological advancements in IVF procedures, high success rates of pregnancy through IVF, changing socio-cultural norms, favorable government regulations & policies, and the reducing costs of IVF. Furthermore, the increasing access to preimplantation genetic testing for selecting the best embryos is expected to generate market growth opportunities in the coming years.

Key Findings

• By Type: The Natural IVF Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024
• By Product: The Instruments Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024
• By Cycle: The Frozen Non-donor IVF Cycles Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024
• By Application: The Human Reproduction Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024
• By End User: The Hospitals Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024

South East Asia In Vitro Fertilization (IVF) Market Growth Drivers

Technological Advancements in IVF Procedures

In Vitro Fertilization (IVF) is becoming an increasingly effective option for couples struggling with infertility. Technological advances, ongoing research, and innovation in the field of reproductive medicine have propelled the demand for IVF. For instance, ovarian tissue cryopreservation is an option for women undergoing cancer treatment who may have compromised fertility. Ovarian tissue cryopreservation allows women to preserve and freeze their ovarian tissue containing viable eggs before undergoing chemotherapy. These tissues can be re-implanted post-treatment.

In addition, advanced time-lapse incubators maintain steady culture conditions for embryos while allowing for continuous monitoring via imaging. They provide optimal embryo development conditions and detailed data on embryo growth, improving the embryo selection process. As research and technology continue to evolve, the chances of success in IVF are steadily improving, which is further driving the growth of the IVF market in South East Asia.

Increasing Infertility Rates

According to the Centers for Disease Control and Prevention (CDC), infertility rates have increased significantly in recent years. For instance, in 2021, the prevalence of infertility per 100,000 individuals was the highest in the Philippines at 3,510.33, followed by Indonesia. As of 2022, the fertility rate average for South East Asian countries was 1.97 births per woman (the Philippines at 2.72 and Singapore at 1.05). Declining fertility rates in the region are attributed to lifestyle factors such as smoking, alcohol use, weight fluctuations, and high stress. Thus, the increasing cases of infertility are driving the demand for IVF.

South East Asia In Vitro Fertilization (IVF) Market Opportunities

Increasing Access to Preimplantation Genetic Testing (PGT) for Selecting the Best Embryos

Preimplantation Genetic Testing (PGT) is a procedure for identifying genetic abnormalities in embryos created for the IVF process. Abnormal embryo genes are one of the common reasons for the failure of pregnancy through IVF. PGT ensures that embryos with the correct number of chromosomes are used, reducing the chances of failure. Preimplantation genetic testing is also carried out for monogenic disorders, structural chromosomal abnormalities, whole chromosome aneuploidy, and other disorders for increasing live birth rates and decreasing overall pregnancy failure rates. Although preimplantation genetic testing cannot identify all genetic abnormalities, prenatal genetic screening can also be performed. For instance, in September 2024, The HiFi Solves Sub-fertility Consortium collaborated with five leading centers across the Asia-Pacific region, such as Singapore's KK Women’s and Children’s Hospital (KKH). This collaboration aims to enhance the diagnosis and treatment of subfertility and recurrent pregnancy loss by using advanced sequencing technologies. Thus, growing collaborations for PGT are expected to create opportunities for market growth.

South East Asia In Vitro Fertilization (IVF) Market Analysis: Key Findings

By Product: The Instruments Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market

Based on product, the South East Asia In Vitro Fertilization (IVF) market is segmented into instruments, reagents & media, and accessories. In 2024, the instruments segment is expected to account for the largest share of the South East Asia IVF market. The instruments segment is further categorized into imaging systems, ovum aspiration pumps, micromanipulator systems, gas analyzers, incubators, laser analyzers, cry systems, sperm separation devices, sperm analyzer systems, sterile cabinets, and other instruments.

The large share of this segment is attributed to the increasing demand for innovative instruments such as time-lapse incubators, as these incubators enable the monitoring of IVF procedures and assist in the classification of healthy embryos with the highest probability of implantation to achieve higher fertility rates. The rising demand for advanced instruments such as imaging systems, the increasing number of fertility clinics, and the rising demand for advanced technologies for IVF procedures also support the segment’s large share.

Imaging systems are utilized to determine embryo quality, morphology, and developmental stage. Embryologists can utilize high-resolution imaging to analyze embryos for parameters such as cell fragmentation, quantity, and symmetry, which helps them select the most promising embryos for transfer. In addition, imaging systems are used to evaluate and monitor fertility processes such as fertilization rates, sperm-egg interactions, and pronuclei production. In addition, technological advancements in imaging systems offer greater embryo visibility, allowing for better embryo selection and quality assessment, assisting in the precise measurement of embryo growth stages, and resulting in increased IVF success rates. Additionally, the automation features of imaging systems accelerate the IVF process, reducing embryologists' manual effort and improving overall laboratory efficiency.

Geographic Analysis

Indonesia to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024

In 2024, Indonesia is expected to account for the largest share of the South East Asia In Vitro Fertilization (IVF) market. Indonesia’s significant market share is attributed to the decreasing fertility rates, growing awareness regarding fertility testing, large demographics, advancements in reproductive technology, and evolving regulatory standards in the country.

Fertility rates in Indonesia have steadily decreased in the past few years due to health issues and socioeconomic changes. According to Macrotrends LLC (U.S.), in 2024, the fertility rate in Indonesia was 2.204 births per woman (2.220 births per woman in 2023 and 2.240 births per woman in 2022). Thus, decreasing fertility rates are increasing the demand for IVF treatments as more couples seek reproductive technologies to overcome infertility challenges.

However, Singapore is slated to register the highest growth rate during the forecast period. The robust healthcare infrastructure, medical tourism, increasing infertility rates, government initiatives and subsidies for fertility treatments, and flexible policies allowing for advancements in IVF technology support the high growth of the IVF market in Singapore. The country’s low fertility rates are attributed to various factors such as delayed parenthood, changing lifestyles, exposure to pollutants, and lack of fertility awareness, increasing the demand for IVF products in Singapore.

South East Asia In Vitro Fertilization (IVF) Market: Key Companies

The report provides a competitive landscape based on an extensive assessment of the leading market players’ offerings, geographic presence, and the key growth strategies adopted by them in recent years (2021-2024). The key players operating in the South East Asia In Vitro Fertilization (IVF) market are Sansure Biotech Inc. (China), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Illumina, Inc. (U.S.), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Abbott Laboratories (U.S.), and Agilent Technologies Inc. (U.S.), among others.

South East Asia In Vitro Fertilization (IVF) Market Overview: Latest Developments from Key Industry Players

• In September 2024, Alpha IVF Group Bhd (Malaysia) expanded its presence in South East Asia by establishing an IVF center in Manila, Philippines. The main objective of the project was to serve the Philippines' 115 million population, where lowering fertility rates indicate an increasing demand for modern reproductive care.
• In October 2023, Cryoport, Inc. (U.S.) signed a three-year supply chain solutions agreement with Monash IVF Group Limited (Australia) for delivering cryogenic logistic solutions and ISO-certified risk mitigation processes for the transportation of patients’ reproductive material across Australia and South East Asia.
• In June 2023, the IVF provider Generation Prime launched its first clinics in Thailand and Malaysia to offer advanced fertility treatments.

South East Asia In Vitro Fertilization Market Research Summary

Key questions answered in the south east asia in vitro fertilization market report: